L 693989

Known as: L-693,989, L-Proline, N2-(10,12-dimethyl-1-oxotetradecyl)-(4R,5R)-4,5-dihydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(4-(phosphonooxy)phenyl)-L-threonyl-threo-3-hydroxy-L-glutaminyl-3-hydroxy-, cyclic (6-1)-peptide, monosodium salt, 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2010
01219922010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Pneumocandins inhibit beta-1,3-glucan synthesis preventing the development of Pneumocystis cysts that are absent from the lungs… (More)
  • figure 1
Is this relevant?
1995
1995
The pneumocandins are semisynthetic analogs of echinocandin-like compounds that have shown efficacy in animal models of systemic… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The lipopeptide antifungal agents, echinocandins, papulacandins, and pneumocandins, kill Candida albicans by inhibiting glucan… (More)
Is this relevant?
1994
1994
Water-soluble pneumocandin L-693,989, a potent antipneumocystis agent in the rat model for Pneumocystis carinii pneumonia (PCP… (More)
Is this relevant?
1992
1992
Water-soluble lipopeptide L-693,989 was evaluated for its antipneumocystis activity in rats. Rats from colonies with latent… (More)
Is this relevant?